D-JNKI-1 (AM-111) is a highly effective and cell-permeable peptide inhibitor.

JNK3 inhibitor-1 is a highly potent and selective compound that specifically inhibits JNK3 with an impressive IC50 value of 0.005 μM. In addition to its remarkable inhibitory effects, JNK3 inhibitor-1 possesses excellent oral bioavailability and the ability to efficiently penetrate the brain.

Peptide comprising residues 33 - 57 of the JNK binding (δ) domain of human c-Jun. Disrupts JNK/c-Jun interaction leading to inhibition of serum-induced c-Jun phosphorylation, up-regulation of p21cip/waf and modulation of inflammatory gene expression. Spec

Licopyranocoumarin could as a potent neuroprotective drug via markedly blocked MPP+-induced neuronal PC12D cell death and disappearance of mitochondrial membrane potential, which were mediated by JNK.

Isopedicin has anti-inflammatory functions, it inhibits the O(2)(*)(-) production in human neutrophils by an elevation of cellular cAMP and activation of PKA through its inhibition of cAMP-specific PDE.

3,5-Dicaffeoyl-epi-quinic acid shows anti-inflammatory activity, it may improve mast cell-mediated inflammatory diseases.

SR18662 是 ML264 类似物，可抑制 Krüppel 样因子 5 (KLF5)，IC50 为 4.4 nM，降低多种结直肠癌细胞系的活力并诱导细胞凋亡。

2-(4-methoxyphenyl)-2-oxoethyl 2-hydroxy-5-methylbenzoate 是一种用于增强认知功能的促神经药物，通过增加大脑中乙酰胆碱的合成和释放以及通过抑制乙酰胆碱酯酶对乙酰胆碱的分解而发挥作用。

ML264 (CID-51003603) 是抗肿瘤剂，能够特异性地抑制 Krüppel 样因子 5 表达。